Clinical Research Directory
Browse clinical research sites, groups, and studies.
Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test
Sponsor: Grand Hôpital de Charleroi
Summary
The pathological anatomy laboratory, which is managed by the IPG, would involve monitoring patients being treated for cancer and receiving care at the GHDC in order to take blood samples from those in whom the presence of plasma ctDNA carrying a mutation in a specific gene is suspected - a mutation detectable by the TST79 test.
Official title: Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test at the Department of Pathology at the Grand Hôpital de Charleroi.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2026-09-15
Completion Date
2028-12-30
Last Updated
2026-10-09
Healthy Volunteers
No
Conditions
Interventions
Gene-alteration pair (G-A)
Point mutations, small insertions or deletions (indels), gene fusions, copy number amplifications.
Locations (1)
Grand Hôpital de Charleroi
Charleroi, Hainaut, Belgium